On July 22, Celsius Holdings fell 5.06% in regular trading, trading at $27.91/share with turnover of $263 million, approaching its 52-week low of $27.47.

The decline comes amid a confluence of negative catalysts including heavy insider selling and a series of analyst price target reductions. Needham cut its target to $55 from $75 on July 9, UBS lowered its target to $50 from $55 on June 30, and Bank of America Securities reduced its target to $45 from $55 in late June. Despite maintaining buy ratings, the successive downgrades reflect growing concerns over the company's near-term outlook.

Fundamentally, UBS has flagged continued deceleration in Celsius's core business as the company undergoes SKU rationalization. Additionally, the company faces a Texas Attorney General investigation over its marketing of high-caffeine drinks to youth. Although Q1 results beat estimates with adjusted EPS of $0.41 versus the $0.30 consensus, the multiple headwinds have eroded investor confidence, pushing shares sharply lower.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)